These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 742355)

  • 21. Melphalan and methotrexate in advanced breast cancer.
    Priestman TJ; Salaman PF
    Cancer Treat Rep; 1978 Dec; 62(12):2111-2. PubMed ID: 751718
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer.
    Danforth DN; Lippman ME; McDonald H; Bader J; Egan E; Lampert M; Steinberg SM; Swain SM
    Am Surg; 1990 Jan; 56(1):6-11. PubMed ID: 2153011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical adjuvant hormonal therapy with high dose medroxyprogesterone acetate (MAP) in breast cancer. Results 36 months after mastectomy.
    Pannuti F; Martoni A; Fruet F; Di Marco AR; Piana E; Saccani-Jotti G; Manfredi D; Mattioli G; Barbanti F; Battelli T; Franchini A; Marrano D; Lungarotti F; Bergnach A
    Panminerva Med; 1982; 24(3):187-94. PubMed ID: 7177683
    [No Abstract]   [Full Text] [Related]  

  • 24. Coley's toxins and chemotherapy in treatment of breast carcinosarcoma: case report.
    Chandler JJ; Crisera RV; Fletcher WS
    Am Surg; 1969 May; 35(5):377-83. PubMed ID: 5782243
    [No Abstract]   [Full Text] [Related]  

  • 25. Controlled trial of adjuvant chemotherapy with melphalan for breast cancer.
    Rubens RD; Hayward JL; Knight RK; Bulbrook RD; Fentiman IS; Chaudary M; Howell A; Bush H; Crowther D; Sellwood RA; George WD; Howat JM
    Lancet; 1983 Apr; 1(8329):839-43. PubMed ID: 6132179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
    Cowan K; Lippman M
    Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter: New hope in breast cancer treatment.
    Ackland TH
    Med J Aust; 1975 Jul; 2(4):151. PubMed ID: 808694
    [No Abstract]   [Full Text] [Related]  

  • 28. Breast cancer management.
    Maddox WA; Laws HL; Carpenter JT
    J Med Assoc State Ala; 1974 Dec; 44(6):293-302. PubMed ID: 4214889
    [No Abstract]   [Full Text] [Related]  

  • 29. L-phenylalanine mustard, doxorubicin, and vincristine in advanced breast cancer: a pilot study.
    Tormey DC; Bull JM; Lipman ML
    Cancer Treat Rep; 1980; 64(8-9):1015-6. PubMed ID: 7448819
    [No Abstract]   [Full Text] [Related]  

  • 30. [Polychemotherapy in advanced tumor of the breast. Our preliminary results].
    Neretto G; Giovanelli E; Fassio D
    Minerva Ginecol; 1977 Apr; 29(4):335-40. PubMed ID: 887240
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adjuvant chemotherapy of primary breast cancer].
    Heuson JC; Mattheiem WH
    Acta Chir Belg; 1977; 76(4):437-43. PubMed ID: 919991
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjuvant androgen treatment of operable breast cancer--a 20 year analysis.
    Karydas I; Fentiman IS; Tong D; Bulbrook RD; Hayward JL
    Eur J Surg Oncol; 1987 Apr; 13(2):113-7. PubMed ID: 3556591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Results of, and indications for adjuvant chemotherapy in breast cancer].
    Brunner KW; Goldhirsch A; Joss R; Sonntag RW; Tschopp L
    Schweiz Med Wochenschr; 1981 Jun; 111(23):838-45. PubMed ID: 7268339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the outcomes of non-randomised chemotherapy regimens in node positive breast cancer.
    Kuru B; Camlibel M; Dinc S; Gulcelik MA; Atalay C; Alagol H
    J Exp Clin Cancer Res; 2005 Sep; 24(3):363-72. PubMed ID: 16270522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent progress in multimodal therapy for resectable breast cancer.
    Bonadonna G
    Isr J Med Sci; 1981; 17(9-10):916-21. PubMed ID: 7309481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Appraising current therapy for breast cancer. 3. Hormonal manipulation and chemotherapy.
    Segaloff A
    Postgrad Med; 1976 Sep; 60(9):191-3. PubMed ID: 822403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immediate breast reconstruction after mastectomy increases wound complications: however, initiation of adjuvant chemotherapy is not delayed.
    Mortenson MM; Schneider PD; Khatri VP; Stevenson TR; Whetzel TP; Sommerhaug EJ; Goodnight JE; Bold RJ
    Arch Surg; 2004 Sep; 139(9):988-91. PubMed ID: 15381618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy in recurrent carcinoma of the breast.
    Stocks LH; Shingleton WW
    N C Med J; 1975 Nov; 36(11):673-5. PubMed ID: 1061862
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjuvant intermittent chemo-immunotherapy of breast cancer. A prospective study.
    Schreml W; Betzler M; Lang M; Lohrman HP; Kubitza P; Schlag P; Flad HD; Herfarth C; Heimpel H
    Eur J Cancer (1965); 1980; Suppl 1():165-8. PubMed ID: 7032927
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.